Lunai Bioworks (LNAI) Total Debt (QoQ) (2011 - 2022)
Lunai Bioworks (LNAI) Total Debt (QoQ) (2011 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Lunai Bioworks |
95.85 Mn |
92.70 Mn |
20,942.00 |
| Date | Value |
|---|
| Sep 30, 2022 |
1.63% |
| Sep 30, 2021 |
1.62% |
| Jun 30, 2021 |
-38.59% |
| Mar 31, 2021 |
9.69% |
| Dec 31, 2020 |
-8.26% |
| Sep 30, 2020 |
-4.55% |
| Jun 30, 2020 |
19.18% |
| Mar 31, 2020 |
50.88% |
| Dec 31, 2019 |
-20.04% |
| Sep 30, 2019 |
-4.73% |
| Jun 30, 2019 |
-76.21% |
| Mar 31, 2019 |
0.92% |
| Dec 31, 2018 |
10.17% |
| Sep 30, 2018 |
-6.41% |
| Dec 31, 2013 |
0.00% |
| Mar 31, 2013 |
-95.42% |
| Dec 31, 2012 |
2,081.30% |
| Sep 30, 2012 |
15.04% |
| Jun 30, 2012 |
49.47% |
| Mar 31, 2012 |
29.01% |
